title: Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
authors.affiliation: Multi-Organ Transplant Service, University Hospital, London, Ontario, Canada.
authors.forename: A I
authors.initials: AI
authors.lastname: Lazarovits
authors.forename: J
authors.initials: J
authors.lastname: Rochon
authors.forename: L
authors.initials: L
authors.lastname: Banks
authors.forename: D J
authors.initials: DJ
authors.lastname: Hollomby
authors.forename: N
authors.initials: N
authors.lastname: Muirhead
authors.forename: A M
authors.initials: AM
authors.lastname: Jevnikar
authors.forename: M J
authors.initials: MJ
authors.lastname: White
authors.forename: P L
authors.initials: PL
authors.lastname: Amlot
authors.forename: L
authors.initials: L
authors.lastname: Beauregard-Zollinger
authors.forename: C R
authors.initials: CR
authors.lastname: Stiller
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology*; D019011:Antigens, CD7; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D002102:Cadaver; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D051379:Mice; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D019011:Antigens, CD7; D000945:Antigens, Differentiation, T-Lymphocyte; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D011993:Recombinant Fusion Proteins; C079847:SDZ CHH 380